Vasculitis & polymyalgia rheumatica
Assessing the efficacy of anticoagulation therapy in the treatment of vascular Behçet's disease: a systematic review
Authors' conclusion
AC therapy can be beneficial in certain contexts of VBD, particularly in reducing thrombosis recurrence and managing postoperative complications. However, the benefits of AC are not uniformly demonstrated across all patient settings
Study context
- Population
- Studies investigating the impact of anticoagulation on vascular behçet's disease (BD) outcomes; PubMed, Embase, Web of Science and Scopus up to January 202434 studies
- Comparison
- Anticoagulation in vascular BD
- Outcome
- Efficacy of anticoagulation in vascular BD
Methodological detailsPRISMA guidelines, Joanna Briggs Institute tools for data extraction and risk of bias assessment
- PRISMA guidelines
- Joanna Briggs Institute tools for data extraction and risk of bias assessment
Pooled result
As reported in the abstract
Anticoagulation (AC) coverage across studies
10.8% to 98.6%
Safety
Safety of anticoagulation
- Generally favourable, with low incidences of significant bleeding
Original publication
Assessing the efficacy of anticoagulation therapy in the treatment of vascular Behçet's disease: a systematic review. Clin Exp Rheumatol. Published 5 August 2024. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →